Piperazinyl substituted cyclohexane 1,4-diamines

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/496 (2006.01) C07D 401/04 (2006.01)

Patent

CA 2603360

The present invention relates to piperazine substituted cyclohexane-1,4- diamine compounds of Formula (I) and pharmaceutically acceptable forms thereof, as .alpha.1a/.alpha.1d adrenoreceptor modulators for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms. The present invention also relates to pharmaceutical compositions comprising said new compounds, new processes to prepare these new compounds and new uses as a medicine as well as methods of treatment.

L~invention concerne des composés de cyclohexane-1,4-diamine pipérazine-substitués de Formule (I) et leurs formes pharmaceutiquement acceptables, en tant que modulateurs de l~adrénorécepteur .alpha.1a/.alpha.1d pour le traitement de l~hypertrophie bénigne de la prostate et de la sténose urétrale. L~invention concerne également des compositions pharmaceutiques comprenant lesdits nouveaux composés, de nouveaux procédés de fabrication de ces nouveaux composés et de nouvelles utilisations en tant que médicaments ainsi que de nouvelles méthodes de traitement.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Piperazinyl substituted cyclohexane 1,4-diamines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Piperazinyl substituted cyclohexane 1,4-diamines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperazinyl substituted cyclohexane 1,4-diamines will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1620220

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.